Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Preferred Stock Liabilities (2018 - 2022)

Harte Hanks (HHS) has disclosed Preferred Stock Liabilities for 5 consecutive years, with $9.7 million as the latest value for Q3 2022.

  • On a quarterly basis, Preferred Stock Liabilities changed 0.0% to $9.7 million in Q3 2022 year-over-year; TTM through Sep 2022 was $9.7 million, a 0.0% change, with the full-year FY2021 number at $9.7 million, changed 0.0% from a year prior.
  • Preferred Stock Liabilities was $9.7 million for Q3 2022 at Harte Hanks, roughly flat from $9.7 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $9.7 million in Q1 2018 to a low of $9.7 million in Q1 2018.
  • A 5-year average of $9.7 million and a median of $9.7 million in 2018 define the central range for Preferred Stock Liabilities.
  • Biggest YoY gain for Preferred Stock Liabilities was 0.0% in 2019; the steepest drop was 0.0% in 2019.
  • Harte Hanks' Preferred Stock Liabilities stood at $9.7 million in 2018, then changed by 0.0% to $9.7 million in 2019, then changed by 0.0% to $9.7 million in 2020, then changed by 0.0% to $9.7 million in 2021, then changed by 0.0% to $9.7 million in 2022.
  • Per Business Quant, the three most recent readings for HHS's Preferred Stock Liabilities are $9.7 million (Q3 2022), $9.7 million (Q2 2022), and $9.7 million (Q1 2022).